Neutrophil-Linked Inflammatory Mechanisms and Biomarkers in Diabetic Microvascular Complications
Diabetes & Metabolism Journal · 01.05.2026 · 50 (3) · 450-471
DOI: 10.4093/dmj.2025.1034 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes & Metabolism Journal, erschienen am 01.05.2026. Verfasst von Junseo Kim und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Science, Chungnam National University College of Medicine, Daejeon, Korea. Hauptthemen laut MEDLINE: Neutrophils, Diabetic Angiopathies, Inflammation. Die Arbeit nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, Korea Health Industry Development Institute.
Abstract (Originalsprache)
Diabetic microvascular complications, including nephropathy, retinopathy, and neuropathy, are major causes of morbidity in diabetes. Increasing evidence highlights neutrophils as key contributors to the chronic inflammatory processes underlying these complications. In the diabetic environment, neutrophils exhibit impaired recruitment, defective phagocytosis, dysregulated degranulation, and excessive production of reactive oxygen species and neutrophil extracellular traps (NETs). These dysfunctions not only reduce pathogen clearance but also exacerbate tissue injury through persistent low-grade inflammation. Furthermore, neutrophils interact with other immune cells, such as macrophages, dendritic cells, T cells, and B cells, perpetuating immune imbalance and tissue damage. Various neutrophil-derived cytokines and granular proteins also influence vascular permeability and endothelial dysfunction. In recent years, neutrophil-related biomarkers—such as absolute neutrophil count, neutrophil-to-lymphocyte ratio, platelet-to-neutrophil ratio, and systemic immune-inflammation index—have gained attention as accessible and cost-effective tools for predicting and monitoring diabetic microvascular complications. This review summarizes the multifaceted roles of neutrophils in the pathogenesis of diabetic microvascular disease and highlights emerging clinical applications of neutrophil-based inflammatory biomarkers. A better understanding of neutrophil-driven mechanisms may open new avenues for early diagnosis, therapeutic intervention, and personalized care in diabetic patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Science, Chungnam National University College of Medicine, Daejeon, Korea.
- Brain Korea 21 FOUR Project for Medical Science, Chungnam National University, Daejeon, Korea.
- Chungnam National University College of Medicine, Daejeon, Korea.
- Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
- Department of Biochemistry, Chungnam National University College of Medicine, Daejeon, Korea.
- System Network Inflammation Control Research Center, Chungnam National University, Daejeon, Korea.
Förderung
- National Research Foundation of Korea
- Ministry of Science and ICT
- Korea Health Industry Development Institute
- Ministry of Health and Welfare
Zitieren
APA
Kim, J., Jung, D., Kang, D. H., Kim, H., Park, J. O., Heo, J. Y., Lee, S. E., Kim, H. J., Lee, J. H., Kang, Y. E., & Ku, B. J. (2026). Neutrophil-Linked Inflammatory Mechanisms and Biomarkers in Diabetic Microvascular Complications. Diabetes & Metabolism Journal, 50(3), 450-471. https://doi.org/10.4093/dmj.2025.1034
Vancouver
Kim J, Jung D, Kang DH, Kim H, Park JO, Heo JY, et al. Neutrophil-Linked Inflammatory Mechanisms and Biomarkers in Diabetic Microvascular Complications. Diabetes & Metabolism Journal. 2026;50(3):450-471. doi:10.4093/dmj.2025.1034
BibTeX
@article{Kim2026,
author = {Kim, Junseo and Jung, Daeun and Kang, Da Hyun and Kim, Hyeongseok and Park, Junyoung O and Heo, Jun Young and Lee, Seong Eun and Kim, Hyun Jin and Lee, Ju Hee and Kang, Yea Eun and Ku, Bon Jeong},
title = {Neutrophil-Linked Inflammatory Mechanisms and Biomarkers in Diabetic Microvascular Complications},
journal = {Diabetes & Metabolism Journal},
year = {2026},
volume = {50},
number = {3},
pages = {450--471},
doi = {10.4093/dmj.2025.1034}
}
EUVIMED